OPKO HEALTH (XCY MU) stock market data APIs
€1.302
0(0%)
as of October 22, 2025
Try our APIs with
free plan!
OPKO HEALTH Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for XCY.MU.
Prev. Close
1.302
Open
1.302
High
1.302
Low
1.302
52 wk Range
1.0526-1.822
Market Cap
2 335 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get OPKO HEALTH data using free add-ons & libraries
Get OPKO HEALTH Fundamental Data
OPKO HEALTH Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
OPKO HEALTH News
New
OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. OPKO Health, Inc. is one of them. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with operatio...
44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently
Key Insights OPKO Health's significant insider ownership suggests inherent interests in company's expansion A total of 5 investors have a majority stake in the company with 51% ownership Recent purch...
Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
Entera Bio Ltd. ENTX recently reported encouraging pharmacokinetic data, underscoring the potential of its first-in-class oral GLP-2 analog therapy for patients with short bowel syndrome (SBS). The fi...
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Labcorp LH recently completed the acquisition of select assets of BioReference Health, a wholly owned subsidiary of OPKO Health, Inc. OPK, a multinational biopharmaceutical and diagnostics company. Th...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
